61 related articles for article (PubMed ID: 18502261)
1. Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.
Emanuele E; Peros E; Minoretti P; Falcone C; D'Angelo A; Montagna L; Geroldi D
BMC Cardiovasc Disord; 2003 Dec; 3():12. PubMed ID: 14670093
[TBL] [Abstract][Full Text] [Related]
2. Lp(a) Levels in Relatives of Patients with Acute Coronary Syndrome and Elevated Lp(a): HER(a) Study.
Fernández-Olmo MR; Bailen MC; Martínez Quesada M; Rus Mansilla C; Martin Toro M; López Suarez A; Lucas García M; Cortez Quiroga G; Calvo Bernal B; Ortiz Cruces S; Torres Llergo J; García Ruano A; Fernández Anguita M; Franco D; Cordero A
J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673529
[No Abstract] [Full Text] [Related]
3. Clinical Value of the Diagonal Earlobe Crease in Patients with Chest Pain for Diagnosing Coronary Heart Disease.
Gao J; Dou J; Yang HH; Guo RL; Jiang C; Tse G; Liu T; Liu JW; Luo DL
Int J Gen Med; 2024; 17():1557-1569. PubMed ID: 38680192
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.
Zhang Y; He H; Zeng YP; Yang LD; Jia D; An ZM; Jia WG
Lipids Health Dis; 2020 Jun; 19(1):134. PubMed ID: 32527258
[TBL] [Abstract][Full Text] [Related]
5. The Ratio of Oxidized Lipoprotein(a) to Native Lipoprotein(a) and the Endothelial Function in Patients with Type 2 Diabetes Mellitus.
Kotani K; Yamada S; Takahashi H; Iwazu Y; Yamada T
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623352
[TBL] [Abstract][Full Text] [Related]
6. South Asian Cardiovascular Disease & Cancer Risk: Genetics & Pathophysiology.
Palaniappan L; Garg A; Enas E; Lewis H; Bari S; Gulati M; Flores C; Mathur A; Molina C; Narula J; Rahman S; Leng J; Gany F
J Community Health; 2018 Dec; 43(6):1100-1114. PubMed ID: 29948525
[TBL] [Abstract][Full Text] [Related]
7. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
[TBL] [Abstract][Full Text] [Related]
8. Lipoprotein(a) and cardiovascular disease in diabetic patients.
Qi Q; Qi L
Clin Lipidol; 2012 Aug; 7(4):397-407. PubMed ID: 23136583
[TBL] [Abstract][Full Text] [Related]
9. Serum lipoprotein(a) levels are greater in female than male patients with type-2 diabetes.
Nakhjavani M; Morteza A; Esteghamati A; Khalilzadeh O; Zandieh A; Safari R
Lipids; 2011 Apr; 46(4):349-56. PubMed ID: 21153771
[TBL] [Abstract][Full Text] [Related]
10. Long-term lifestyle intervention lowers the incidence of stroke in Japanese patients with type 2 diabetes: a nationwide multicentre randomised controlled trial (the Japan Diabetes Complications Study).
Sone H; Tanaka S; Iimuro S; Tanaka S; Oida K; Yamasaki Y; Oikawa S; Ishibashi S; Katayama S; Yamashita H; Ito H; Yoshimura Y; Ohashi Y; Akanuma Y; Yamada N;
Diabetologia; 2010 Mar; 53(3):419-28. PubMed ID: 20054522
[TBL] [Abstract][Full Text] [Related]
11. [Elevated levels of lipoprotein(a) are present in subjects with early ischemic cardiopathy and with a familial history of ischemic cardiopathy].
Saitta A; Castaldo M; Sardo A; Cinquegrani M; Bonaiuto M; Zema M; Gravina M; Mangano C
Minerva Med; 1999; 90(5-6):151-8. PubMed ID: 10780189
[TBL] [Abstract][Full Text] [Related]
12. The relationship between lipoprotein(a) and the complications of diabetes mellitus.
Koschinsky ML; Marcovina SM
Acta Diabetol; 2003 Jun; 40(2):65-76. PubMed ID: 12861403
[TBL] [Abstract][Full Text] [Related]
13. Apheresis in coronary heart disease with elevated Lp (a): a review of Lp (a) as a risk factor and its management.
Keller C
Ther Apher Dial; 2007 Feb; 11(1):2-8. PubMed ID: 17309568
[TBL] [Abstract][Full Text] [Related]
14. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
[TBL] [Abstract][Full Text] [Related]
15. Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.
Murase T; Okubo M; Amemiya-Kudo M; Hiraga T; Oka J; Shimada M; Igarashi T
Metabolism; 2007 Sep; 56(9):1187-91. PubMed ID: 17697860
[TBL] [Abstract][Full Text] [Related]
16. [Coronary heart disease and lipoprotein (a): relationship with other lipid cardiovascular risk factors].
Nogués X; Sentí M; Pedro-Botet J; Molina L; Serrat R; Pons S; Rubiés-Prat J
Med Clin (Barc); 1992 Feb; 98(5):171-4. PubMed ID: 1532436
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
